Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$7,636,267
+$972,374 QoQ
Shares Held
30,346
-1.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
5.89%
of 13F equity value
Holder Rank
#1,057
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jackson, Grant Investment Advisers, Inc. holds $16,628,871 across 11 Drug Manufacturers - General names. ABBV ranks #1 (45.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
30,346 | $7,636,267 | |
| 2 | JNJ |
Johnson & Johnson
|
13,554 | $3,442,309 | |
| 3 | LLY |
ELI LILLY & Co
|
2,102 | $2,521,202 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,533 | $1,610,490 | |
| 5 | AMGN |
Amgen Inc
|
2,382 | $862,569 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,529 | $203,340 | |
| 7 | PFE |
Pfizer Inc
|
6,680 | $160,854 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,035 | $130,761 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,636,267 | 30,346 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $6,663,893 | 30,640 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $7,128,202 | 31,197 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $7,280,543 | 31,444 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,811,205 | 31,307 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $6,528,643 | 31,160 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $5,532,511 | 31,134 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $6,092,060 | 30,849 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $5,265,492 | 30,699 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $5,629,439 | 30,914 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,803,605 | 30,997 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $4,592,836 | 30,812 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $4,129,070 | 30,647 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $4,856,800 | 30,475 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $4,885,631 | 30,231 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $4,037,842 | 30,086 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,582,394 | 29,919 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $4,824,069 | 29,758 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $4,006,079 | 29,587 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $3,179,144 | 29,472 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $3,407,134 | 30,248 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $3,302,441 | 30,516 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $3,245,680 | 30,291 | Shares | Sole | 2021-03-03 | |
| 2020-09-30 | $2,637,159 | 30,108 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,984,573 | 30,399 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,384,061 | 31,291 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||